Light Mode
$2.82 ↑ +0.00 (+0.00%) Trading Up from the previous close of $2.82, $0.34 below the day’s high of $3.16
+1.76 (+166.04%) / 6M
Momentum, market sentiment, and recent alerts
INDP reads poor: price sits above one of the two key moving averages, the 12-month move is +52.4%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Indaptus Therapeutics, Inc. is a clinical biotechnology company. The firm engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.